Eric Eldering Selected Research

selicrelumab

6/2021

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Eldering Research Topics

Disease

22	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 08/2008
16	Neoplasms (Cancer) 01/2021 - 07/2004
5	Multiple Myeloma 01/2021 - 09/2010
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 06/2011
3	Leukemia 06/2021 - 01/2019
3	Inflammation (Inflammations) 10/2013 - 06/2004
2	Melanoma (Melanoma, Malignant) 01/2021 - 09/2012
2	Infections 10/2019 - 02/2012
2	Lymphocytosis 01/2016 - 03/2012
2	Lymphadenopathy 01/2016 - 03/2012
2	Virus Diseases (Viral Diseases) 09/2012 - 05/2012
2	Human Influenza (Influenza) 02/2012 - 06/2010
2	Rheumatoid Arthritis 03/2010 - 07/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Disease Progression 06/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	COVID-19 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Starvation 01/2020
1	Reinfection 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2019
1	Primary Myelofibrosis (Myelosclerosis) 10/2019
1	Anemia 11/2013
1	Down Syndrome (Down's Syndrome) 10/2013
1	Persistent Infection 05/2012

Drug/Important Bio-Agent (IBA)

7	venetoclaxIBA 01/2022 - 08/2015
7	Phosphotransferases (Kinase)IBA 01/2021 - 07/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
5	LigandsIBA 01/2017 - 10/2004
4	AntigensIBA 01/2021 - 01/2010
4	ChemokinesIBA 01/2020 - 09/2009
3	ibrutinibIBA 12/2021 - 03/2012
3	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021 - 03/2012
3	CytokinesIBA 01/2020 - 11/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2009 - 08/2008
2	Monoclonal AntibodiesIBA 06/2021 - 06/2011
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2004
2	AntibodiesIBA 08/2015 - 06/2011
2	Dasatinib (BMS 354825)FDA Link 01/2014 - 12/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 09/2002
2	Biological ProductsIBA 07/2013 - 08/2007
2	Pharmaceutical PreparationsIBA 03/2012 - 09/2010
1	Cyclin D1IBA 01/2022
1	selicrelumabIBA 06/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Syk KinaseIBA 01/2021
1	navitoclaxIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Bendamustine Hydrochloride FDA Link 12/2020
1	Rituximab (Mabthera)FDA Link 12/2020
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Bispecific AntibodiesIBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	Immunodominant EpitopesIBA 01/2020
1	Janus Kinase InhibitorsIBA 10/2019
1	idelalisibIBA 10/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2019
1	EnzymesIBA 01/2019
1	pevonedistatIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	CC ChemokinesIBA 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA 01/2016
1	PlatinumIBA 01/2015
1	fludarabineIBA 01/2014
1	Superoxides (Superoxide)IBA 10/2013
1	CatalaseIBA 10/2013
1	Glutathione PeroxidaseIBA 10/2013
1	InterleukinsIBA 10/2013
1	Superoxide DismutaseIBA 10/2013
1	Free Radical ScavengersIBA 10/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013
1	Toll-Like Receptor 3IBA 09/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2012
1	Double-Stranded RNA (RNA, Double Stranded)IBA 09/2012
1	Antiviral Agents (Antivirals)IBA 09/2012
1	Fas Ligand Protein (Fas Ligand)IBA 05/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2012

Therapy/Procedure

8	Therapeutics 01/2022 - 06/2011
4	Immunotherapy 01/2021 - 09/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2009